The proteins that control entry and exit from the cell nucleus influence aging, Vanderbilt researchers have discovered.
Vanderbilt-Ingram Cancer Center investigators have identified the mechanisms used by a gene and its binding protein to drive tumor growth in several forms of cancer, including non-small cell lung cancer.
A new study from Vanderbilt introduces an adroit and flexible strategy to quash attacks on patient privacy and aid the flow of vital research data.
Vanderbilt University researchers have discovered a cleft in a chromosome-binding protein that may hold the key to stopping most cancers in their tracks.
Patients seeking to participate in clinical trials have a new option in online tools for finding studies that might offer hope for their problem or condition.
Sir Stephen O’Rahilly, M.D., an expert in metabolic and endocrine diseases, will deliver the next Flexner Discovery Lecture on Thursday, April 2.